Tapewire

Nasdaq · USD

CYAB

CYABRA, INC.

Export transactions ↓
Tapewire entity
8037
SEC CIK
0002032341
Parsed reports
32

Last 12 months

Inside the activity.

1 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202610
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
July 10, 2026 Filed Jul 13, 2026 21:09 UTC PurchaseCommon Stock Warrants (right to buy) · Derivative 114,940 $0.50 Strike: $0.50 $57,470.00
Disclosure

SEC source: 0001213900-26-077644 · ownership.xml · derivative · entry 3

Flanagan James Francis · CIK 0002055648 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 229,880

Underlying: Common Stock · 114,940 shares

Expires not disclosed

F5 · security: The Reporting Person purchased Series A warrants to purchase up to 53,650 shares of Common Stock (the "Series A Warrants") in the Private Placement.

F6 · derivative.exercise_date: The Series A Warrants will become exercisable upon the receipt of the requisite stockholder approval.

F7 · derivative.expiration_date: The Series A Warrants expire five (5) years following the initial exercise date.

Read SEC document
July 10, 2026 Filed Jul 13, 2026 21:09 UTC PurchaseCommon Stock Warrants (right to buy) · Derivative 114,940 $0.45 Strike: $0.45 $51,723.00
Disclosure

SEC source: 0001213900-26-077644 · ownership.xml · derivative · entry 2

Flanagan James Francis · CIK 0002055648 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 114,940

Underlying: Common Stock · 114,940 shares

Expires not disclosed

F2 · security: The Reporting Person purchased Series B warrants to purchase up to 53,650 shares of Common Stock (the "Series B Warrants") in the Private Placement.

F3 · derivative.exercise_date: The Series B Warrants will become exercisable upon the receipt of the requisite stockholder approval.

F4 · derivative.expiration_date: The Series B Warrants expire twelve (12) months following the initial exercise date.

Read SEC document
July 10, 2026 Filed Jul 13, 2026 21:09 UTC GrantCommon Stock 114,940 $0.44 $49,998.90
Disclosure

SEC source: 0001213900-26-077644 · ownership.xml · nonDerivative · entry 1

Flanagan James Francis · CIK 0002055648 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 224,940

F1 · shares: On July 10, 2026, the Reporting Person purchased 53,650 shares of common stock, par value $0.0001 per share (the "Common Stock"), from the Issuer in a private placement transaction (the "Private Placement") at a purchase price of $0.435 per share.

Read SEC document
July 10, 2026 Filed Jul 13, 2026 21:10 UTC
Daar YossefDirector · Chief Product Officer
PurchaseCommon Stock Warrants (right to buy) · Derivative 53,650 $0.50 Strike: $0.50 $26,825.00
Disclosure

SEC source: 0001213900-26-077646 · ownership.xml · derivative · entry 3

Daar Yossef · CIK 0002045600 · Director · Chief Product Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 107,300

Underlying: Common Stock · 53,650 shares

Expires not disclosed

F5 · security: The Reporting Person purchased Series A warrants to purchase up to 53,650 shares of Common Stock (the "Series A Warrants") in the Private Placement.

F6 · derivative.exercise_date: The Series A Warrants will become exercisable upon the receipt of the requisite stockholder approval.

F7 · derivative.expiration_date: The Series A Warrants expire five (5) years following the initial exercise date.

Read SEC document
July 10, 2026 Filed Jul 13, 2026 21:10 UTC
Daar YossefDirector · Chief Product Officer
PurchaseCommon Stock Warrants (right to buy) · Derivative 53,650 $0.45 Strike: $0.45 $24,142.50
Disclosure

SEC source: 0001213900-26-077646 · ownership.xml · derivative · entry 2

Daar Yossef · CIK 0002045600 · Director · Chief Product Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,650

Underlying: Common Stock · 53,650 shares

Expires not disclosed

F2 · security: The Reporting Person purchased Series B warrants to purchase up to 53,650 shares of Common Stock (the "Series B Warrants") in the Private Placement.

F3 · derivative.exercise_date: The Series B Warrants will become exercisable upon the receipt of the requisite stockholder approval.

F4 · derivative.expiration_date: The Series B Warrants expire twelve (12) months following the initial exercise date.

Read SEC document
July 10, 2026 Filed Jul 13, 2026 21:10 UTC
Daar YossefDirector · Chief Product Officer
GrantCommon Stock 53,650 $0.44 $23,337.75
Disclosure

SEC source: 0001213900-26-077646 · ownership.xml · nonDerivative · entry 1

Daar Yossef · CIK 0002045600 · Director · Chief Product Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 894,199

F1 · shares: On July 10, 2026, the Reporting Person purchased 53,650 shares of common stock, par value $0.0001 per share (the "Common Stock"), from the Issuer in a private placement transaction (the "Private Placement") at a purchase price of $0.435 per share.

Read SEC document
July 10, 2026 Filed Jul 13, 2026 21:08 UTC
Shraga IdoChief Technology Officer
PurchaseCommon Stock Warrants (right to buy) · Derivative 53,650 $0.50 Strike: $0.50 $26,825.00
Disclosure

SEC source: 0001213900-26-077642 · ownership.xml · derivative · entry 3

Shraga Ido · CIK 0002045603 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 107,300

Underlying: Common Stock · 53,650 shares

Expires not disclosed

F5 · security: The Reporting Person purchased Series A warrants to purchase up to 53,650 shares of Common Stock (the "Series A Warrants") in the Private Placement.

F6 · derivative.exercise_date: The Series A Warrants will become exercisable upon the receipt of the requisite stockholder approval.

F7 · derivative.expiration_date: The Series A Warrants expire five (5) years following the initial exercise date.

Read SEC document
July 10, 2026 Filed Jul 13, 2026 21:08 UTC
Shraga IdoChief Technology Officer
PurchaseCommon Stock Warrants (right to buy) · Derivative 53,650 $0.45 Strike: $0.45 $24,142.50
Disclosure

SEC source: 0001213900-26-077642 · ownership.xml · derivative · entry 2

Shraga Ido · CIK 0002045603 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,650

Underlying: Common Stock · 53,650 shares

Expires not disclosed

F2 · security: The Reporting Person purchased Series B warrants to purchase up to 53,650 shares of Common Stock (the "Series B Warrants") in the Private Placement.

F3 · derivative.exercise_date: The Series B Warrants will become exercisable upon the receipt of the requisite stockholder approval.

F4 · derivative.expiration_date: The Series B Warrants expire on the date that is twelve (12) months following the initial exercise date.

Read SEC document
July 10, 2026 Filed Jul 13, 2026 21:08 UTC
Shraga IdoChief Technology Officer
GrantCommon Stock 53,650 $0.00 $0.00
Disclosure

SEC source: 0001213900-26-077642 · ownership.xml · nonDerivative · entry 1

Shraga Ido · CIK 0002045603 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 894,199

F1 · shares: On July 10, 2026, the Reporting Person purchased 53,650 shares of common stock, par value $0.0001 per share (the "Common Stock"), from the Issuer in a private placement transaction (the "Private Placement") at a purchase price of $0.435 per share.

Read SEC document
July 10, 2026 Filed Jul 13, 2026 21:08 UTC
Brahmy DanDirector · Chief Executive Officer
PurchaseCommon Stock Warrants (right to buy) · Derivative 53,650 $0.50 Strike: $0.50 $26,825.00
Disclosure

SEC source: 0001213900-26-077640 · ownership.xml · derivative · entry 3

Brahmy Dan · CIK 0002045607 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 149,446

Underlying: Common Stock · 53,650 shares

Expires not disclosed

F5 · security: The Reporting Person purchased Series A warrants to purchase up to 53,650 shares of Common Stock (the "Series A Warrants") in the Private Placement.

F6 · derivative.exercise_date: The Series A Warrants will become exercisable upon the receipt of the requisite stockholder approval.

F7 · derivative.expiration_date: The Series A Warrants expire five (5) years following the initial exercise date.

Read SEC document
July 10, 2026 Filed Jul 13, 2026 21:08 UTC
Brahmy DanDirector · Chief Executive Officer
PurchaseCommon Stock Warrants (right to buy) · Derivative 53,650 $0.45 Strike: $0.45 $24,142.50
Disclosure

SEC source: 0001213900-26-077640 · ownership.xml · derivative · entry 2

Brahmy Dan · CIK 0002045607 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 95,796

Underlying: Common Stock · 53,650 shares

Expires not disclosed

F2 · security: The Reporting Person purchased Series B warrants to purchase up to 53,650 shares of Common Stock (the "Series B Warrants") in the Private Placement.

F3 · derivative.exercise_date: The Series B Warrants will become exercisable upon the receipt of the requisite stockholder approval.

F4 · derivative.expiration_date: The Series B Warrants expire twelve (12) months following the initial exercise date.

Read SEC document
July 10, 2026 Filed Jul 13, 2026 21:08 UTC
Brahmy DanDirector · Chief Executive Officer
PurchaseCommon Stock 53,650 $0.44 $23,337.75
Disclosure

SEC source: 0001213900-26-077640 · ownership.xml · nonDerivative · entry 1

Brahmy Dan · CIK 0002045607 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 853,052

F1 · shares: On July 10, 2026, the Reporting Person purchased 53,650 shares of common stock, par value $0.0001 per share (the "Common Stock"), from the Issuer in a private placement transaction (the "Private Placement") at a purchase price of $0.435 per share.

Read SEC document
May 14, 2026 Filed May 18, 2026 20:01 UTC
Sandler YaelChief Financial Officer
GrantCommon Stock 40,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-26-058423 · ownership.xml · nonDerivative · entry 1

Sandler Yael · CIK 0001717067 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,000

F1 · shares: On May 14, 2026, the Reporting Person was granted 40,000 restricted stock units ("RSUs") of the Issuer pursuant to the Cyabra, Inc. 2026 Omnibus Equity Incentive Plan, vesting over three years through April 1, 2029. Each RSU represents the right to receive one share of common stock, par value $0.0001 per share.

Read SEC document
May 14, 2026 Filed May 18, 2026 20:01 UTC GrantCommon Stock 110,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-26-058422 · ownership.xml · nonDerivative · entry 1

Flanagan James Francis · CIK 0002055648 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 110,000

F1 · shares: On May 14, 2026, the Reporting Person was granted 110,000 restricted stock units ("RSUs") of the Issuer pursuant to the Cyabra, Inc. 2026 Omnibus Equity Incentive Plan, vesting over three years through April 1, 2029. Each RSU represents the right to receive one share of common stock, par value $0.0001 per share.

Read SEC document
May 14, 2026 Filed May 18, 2026 20:01 UTC
Shraga IdoChief Technology Officer
GrantCommon Stock 130,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-26-058417 · ownership.xml · nonDerivative · entry 1

Shraga Ido · CIK 0002045603 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 840,549

F1 · shares: On May 14, 2026, the Reporting Person was granted 130,000 restricted stock units ("RSUs") of the Issuer pursuant to the Cyabra, Inc. 2026 Omnibus Equity Incentive Plan, vesting in quarterly amounts of 26,000 shares of common stock, par value $0.0001 per share (the "Common Stock") through July 1, 2027. Each RSU represents the right to receive one Common Stock.

Read SEC document
May 14, 2026 Filed May 18, 2026 20:01 UTC
Daar YossefDirector · Chief Product Officer
GrantCommon Stock 130,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-26-058421 · ownership.xml · nonDerivative · entry 1

Daar Yossef · CIK 0002045600 · Director · Chief Product Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 840,549

F1 · shares: On May 14, 2026, the Reporting Person was granted 130,000 restricted stock units ("RSUs") of the Issuer pursuant to the Cyabra, Inc. 2026 Omnibus Equity Incentive Plan, vesting in quarterly amounts of 26,000 shares of common stock, par value $0.0001 per share (the "Common Stock") through July 1, 2027. Each RSU represents the right to receive one Common Stock.

Read SEC document
May 14, 2026 Filed May 18, 2026 20:01 UTC
Heymann EmmanuelChief Revenue Officer
GrantCommon Stock 100,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-26-058418 · ownership.xml · nonDerivative · entry 1

Heymann Emmanuel · CIK 0002045608 · Chief Revenue Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

F1 · shares: On May 14, 2026, the Reporting Person was granted 100,000 restricted stock units ("RSUs") of the Issuer pursuant to the Cyabra, Inc. 2026 Omnibus Equity Incentive Plan, vesting over three years through April 1, 2029. Each RSU represents the right to receive one share of common stock, par value $0.0001 per share.

Read SEC document
May 14, 2026 Filed May 18, 2026 20:01 UTC GrantCommon Stock 100,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-26-058416 · ownership.xml · nonDerivative · entry 1

Madon Michael P · CIK 0001636174 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

F1 · shares: On May 14, 2026, the Reporting Person was granted 100,000 restricted stock units ("RSUs") of the Issuer pursuant to the Cyabra, Inc. 2026 Omnibus Equity Incentive Plan, vesting over three years through April 1, 2029. Each RSU represents the right to receive one share of common stock, par value $0.0001 per share.

Read SEC document
May 14, 2026 Filed May 18, 2026 20:01 UTC
Brahmy DanDirector · Chief Executive Officer
GrantCommon Stock 130,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-26-058420 · ownership.xml · nonDerivative · entry 1

Brahmy Dan · CIK 0002045607 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 799,402

F1 · shares: On May 14, 2026, the Reporting Person was granted 130,000 restricted stock units ("RSUs") of the Issuer pursuant to the Cyabra, Inc. 2026 Omnibus Equity Incentive Plan, vesting in quarterly amounts of 26,000 shares of common stock, par value $0.0001 per share (the "Common Stock") through July 1, 2027. Each RSU represents the right to receive one Common Stock.

Read SEC document
May 14, 2026 Filed May 18, 2026 20:01 UTC
Vu SonnyDirector
GrantCommon Stock 80,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-26-058415 · ownership.xml · nonDerivative · entry 1

Vu Sonny · CIK 0002045863 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 107,329

F1 · shares: On May 14, 2026, the Reporting Person was granted 80,000 restricted stock units ("RSUs") of the Issuer pursuant to the Cyabra, Inc. 2026 Omnibus Equity Incentive Plan, vesting over three years through April 1, 2029. Each RSU represents the right to receive one share of common stock, par value $0.0001 per share.

Read SEC document
March 27, 2026 Filed Apr 1, 2026 01:10 UTC
Daar YossefDirector · Chief Product Officer
GrantCommon Stock 133,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-26-037861 · ownership.xml · nonDerivative · entry 2

Daar Yossef · CIK 0002045600 · Director · Chief Product Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 710,549

F4 · shares: On March 27, 2026, the Reporting Person was granted 133,000 restricted stock units of the Issuer pursuant to the Cyabra, Inc. 2026 Omnibus Equity Incentive Plan (the "2026 Plan") which were fully vested upon grant. Such grant is effective 30 days after the 2026 Israeli Sub-Plan to the 2026 Plan is filed with the Israel Tax Authority.

F3 · ownership.nature: Held by IBI Trust Management in trust for the Reporting Person.

Read SEC document
March 27, 2026 Filed Apr 1, 2026 01:10 UTC
Daar YossefDirector · Chief Product Officer
GrantCommon Stock 577,549 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-26-037861 · ownership.xml · nonDerivative · entry 1

Daar Yossef · CIK 0002045600 · Director · Chief Product Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 577,549

F1 · shares: Received in connection with the Issuer's business combination with Trailblazer Merger Corporation I ("Trailblazer"), in accordance with the terms of the Merger Agreement, dated July 22, 2024, as amended (the "Merger Agreement"), by and among Trailblazer, Trailblazer Merger Sub, Ltd. ("Merger Sub"), Trailblazer Holdings, Inc. ("Holdings"), and Cyabra Strategy Ltd. ("Cyabra"), pursuant to which (a) Trailblazer merged with and into Holdings, with Holdings as the surviving entity of the merger (the "Parent Merger"), and (b) Merger Sub merged with and into Cyabra, with Cyabra as the surviving entity of the merger (together with the Parent Merger and all other transactions contemplated by the Merger Agreement, the "Business Combination"), following which Merger Sub ceased to exist and Cyabra became a wholly owned subsidiary of Holdings. After giving effect to the Business Combination, Holdings changed its name to the Issuer.

F2 · shares: Pursuant to the Merger Agreement, 160,000 ordinary shares of Cyabra held by the Reporting Person that were outstanding immediately prior to the effective time of the Business Combination (the "Effective Time") were, as of the Effective Time, converted into 577,549 shares of the Issuer.

F1 · price: Received in connection with the Issuer's business combination with Trailblazer Merger Corporation I ("Trailblazer"), in accordance with the terms of the Merger Agreement, dated July 22, 2024, as amended (the "Merger Agreement"), by and among Trailblazer, Trailblazer Merger Sub, Ltd. ("Merger Sub"), Trailblazer Holdings, Inc. ("Holdings"), and Cyabra Strategy Ltd. ("Cyabra"), pursuant to which (a) Trailblazer merged with and into Holdings, with Holdings as the surviving entity of the merger (the "Parent Merger"), and (b) Merger Sub merged with and into Cyabra, with Cyabra as the surviving entity of the merger (together with the Parent Merger and all other transactions contemplated by the Merger Agreement, the "Business Combination"), following which Merger Sub ceased to exist and Cyabra became a wholly owned subsidiary of Holdings. After giving effect to the Business Combination, Holdings changed its name to the Issuer.

F2 · price: Pursuant to the Merger Agreement, 160,000 ordinary shares of Cyabra held by the Reporting Person that were outstanding immediately prior to the effective time of the Business Combination (the "Effective Time") were, as of the Effective Time, converted into 577,549 shares of the Issuer.

F1 · balance_after: Received in connection with the Issuer's business combination with Trailblazer Merger Corporation I ("Trailblazer"), in accordance with the terms of the Merger Agreement, dated July 22, 2024, as amended (the "Merger Agreement"), by and among Trailblazer, Trailblazer Merger Sub, Ltd. ("Merger Sub"), Trailblazer Holdings, Inc. ("Holdings"), and Cyabra Strategy Ltd. ("Cyabra"), pursuant to which (a) Trailblazer merged with and into Holdings, with Holdings as the surviving entity of the merger (the "Parent Merger"), and (b) Merger Sub merged with and into Cyabra, with Cyabra as the surviving entity of the merger (together with the Parent Merger and all other transactions contemplated by the Merger Agreement, the "Business Combination"), following which Merger Sub ceased to exist and Cyabra became a wholly owned subsidiary of Holdings. After giving effect to the Business Combination, Holdings changed its name to the Issuer.

F2 · balance_after: Pursuant to the Merger Agreement, 160,000 ordinary shares of Cyabra held by the Reporting Person that were outstanding immediately prior to the effective time of the Business Combination (the "Effective Time") were, as of the Effective Time, converted into 577,549 shares of the Issuer.

F3 · ownership.nature: Held by IBI Trust Management in trust for the Reporting Person.

Read SEC document
March 27, 2026 Filed Apr 1, 2026 01:22 UTC
Brahmy DanDirector · Chief Executive Officer
GrantStock Option (Right to Buy) · Derivative 42,146 Not disclosed Strike: $0.00 Not disclosed
Disclosure

SEC source: 0001213900-26-037880 · ownership.xml · derivative · entry 3

Brahmy Dan · CIK 0002045607 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,146

Underlying: Common Stock · 42,146 shares

Expires 2033-11-13

F1 · price: Received in connection with the Issuer's business combination with Trailblazer Merger Corporation I ("Trailblazer"), in accordance with the terms of the Merger Agreement, dated July 22, 2024, as amended (the "Merger Agreement"), by and among Trailblazer, Trailblazer Merger Sub, Ltd. ("Merger Sub"), Trailblazer Holdings, Inc. ("Holdings"), and Cyabra Strategy Ltd. ("Cyabra"), pursuant to which (a) Trailblazer merged with and into Holdings, with Holdings as the surviving entity of the merger (the "Parent Merger"), and (b) Merger Sub merged with and into Cyabra, with Cyabra as the surviving entity of the merger (together with the Parent Merger and all other transactions contemplated by the Merger Agreement, the "Business Combination"), following which Merger Sub ceased to exist and Cyabra became a wholly owned subsidiary of Holdings. After giving effect to the Business Combination, Holdings changed its name to the Issuer.

F6 · price: Pursuant to the Merger Agreement, each option to purchase ordinary shares of Cyabra held by the Reporting Person that was outstanding immediately prior to the Effective Time for an aggregate of 11,676 ordinary shares was, as of the Effective Time, cancelled in consideration for the issuance of an option to purchase shares of the Issuer reported herein pursuant to the 2026 Plan, subject to the same terms and conditions as were applicable to the corresponding Cyabra option immediately prior to the Effective Time.

F5 · derivative.exercise_date: The options were fully vested upon grant.

Read SEC document
March 27, 2026 Filed Apr 1, 2026 01:22 UTC
Brahmy DanDirector · Chief Executive Officer
GrantCommon Stock 134,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-26-037880 · ownership.xml · nonDerivative · entry 2

Brahmy Dan · CIK 0002045607 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 669,402

F4 · shares: On March 27, 2026, the Reporting Person was granted 134,000 restricted stock units of the Issuer pursuant to the Cyabra, Inc. 2026 Omnibus Equity Incentive Plan (the "2026 Plan") which were fully vested upon grant.

F3 · ownership.nature: Held by IBI Trust Management in trust for the Reporting Person.

Read SEC document
March 27, 2026 Filed Apr 1, 2026 01:22 UTC
Brahmy DanDirector · Chief Executive Officer
GrantCommon Stock 535,402 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-26-037880 · ownership.xml · nonDerivative · entry 1

Brahmy Dan · CIK 0002045607 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 535,402

F1 · shares: Received in connection with the Issuer's business combination with Trailblazer Merger Corporation I ("Trailblazer"), in accordance with the terms of the Merger Agreement, dated July 22, 2024, as amended (the "Merger Agreement"), by and among Trailblazer, Trailblazer Merger Sub, Ltd. ("Merger Sub"), Trailblazer Holdings, Inc. ("Holdings"), and Cyabra Strategy Ltd. ("Cyabra"), pursuant to which (a) Trailblazer merged with and into Holdings, with Holdings as the surviving entity of the merger (the "Parent Merger"), and (b) Merger Sub merged with and into Cyabra, with Cyabra as the surviving entity of the merger (together with the Parent Merger and all other transactions contemplated by the Merger Agreement, the "Business Combination"), following which Merger Sub ceased to exist and Cyabra became a wholly owned subsidiary of Holdings. After giving effect to the Business Combination, Holdings changed its name to the Issuer.

F2 · shares: Pursuant to the Merger Agreement, 148,324 ordinary shares of Cyabra held by the Reporting Person that were outstanding immediately prior to the effective time of the Business Combination (the "Effective Time") were, as of the Effective Time, converted into 535,402 shares of the Issuer.

F1 · price: Received in connection with the Issuer's business combination with Trailblazer Merger Corporation I ("Trailblazer"), in accordance with the terms of the Merger Agreement, dated July 22, 2024, as amended (the "Merger Agreement"), by and among Trailblazer, Trailblazer Merger Sub, Ltd. ("Merger Sub"), Trailblazer Holdings, Inc. ("Holdings"), and Cyabra Strategy Ltd. ("Cyabra"), pursuant to which (a) Trailblazer merged with and into Holdings, with Holdings as the surviving entity of the merger (the "Parent Merger"), and (b) Merger Sub merged with and into Cyabra, with Cyabra as the surviving entity of the merger (together with the Parent Merger and all other transactions contemplated by the Merger Agreement, the "Business Combination"), following which Merger Sub ceased to exist and Cyabra became a wholly owned subsidiary of Holdings. After giving effect to the Business Combination, Holdings changed its name to the Issuer.

F2 · price: Pursuant to the Merger Agreement, 148,324 ordinary shares of Cyabra held by the Reporting Person that were outstanding immediately prior to the effective time of the Business Combination (the "Effective Time") were, as of the Effective Time, converted into 535,402 shares of the Issuer.

F1 · balance_after: Received in connection with the Issuer's business combination with Trailblazer Merger Corporation I ("Trailblazer"), in accordance with the terms of the Merger Agreement, dated July 22, 2024, as amended (the "Merger Agreement"), by and among Trailblazer, Trailblazer Merger Sub, Ltd. ("Merger Sub"), Trailblazer Holdings, Inc. ("Holdings"), and Cyabra Strategy Ltd. ("Cyabra"), pursuant to which (a) Trailblazer merged with and into Holdings, with Holdings as the surviving entity of the merger (the "Parent Merger"), and (b) Merger Sub merged with and into Cyabra, with Cyabra as the surviving entity of the merger (together with the Parent Merger and all other transactions contemplated by the Merger Agreement, the "Business Combination"), following which Merger Sub ceased to exist and Cyabra became a wholly owned subsidiary of Holdings. After giving effect to the Business Combination, Holdings changed its name to the Issuer.

F2 · balance_after: Pursuant to the Merger Agreement, 148,324 ordinary shares of Cyabra held by the Reporting Person that were outstanding immediately prior to the effective time of the Business Combination (the "Effective Time") were, as of the Effective Time, converted into 535,402 shares of the Issuer.

F3 · ownership.nature: Held by IBI Trust Management in trust for the Reporting Person.

Read SEC document
March 27, 2026 Filed Apr 1, 2026 01:14 UTC
Shraga IdoChief Technology Officer
GrantCommon Stock 133,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-26-037870 · ownership.xml · nonDerivative · entry 2

Shraga Ido · CIK 0002045603 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 710,549

F4 · shares: On March 27, 2026, the Reporting Person was granted 133,000 restricted stock units of the Issuer pursuant to the Cyabra, Inc. 2026 Omnibus Equity Incentive Plan (the "2026 Plan") which were fully vested upon grant. Such grant is effective 30 days after the 2026 Israeli Sub-Plan to the 2026 Plan is filed with the Israel Tax Authority.

F3 · ownership.nature: Held by IBI Trust Management in trust for the Reporting Person.

Read SEC document
March 27, 2026 Filed Apr 1, 2026 01:14 UTC
Shraga IdoChief Technology Officer
GrantCommon Stock 577,549 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-26-037870 · ownership.xml · nonDerivative · entry 1

Shraga Ido · CIK 0002045603 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 577,549

F1 · shares: Received in connection with the Issuer's business combination with Trailblazer Merger Corporation I ("Trailblazer"), in accordance with the terms of the Merger Agreement, dated July 22, 2024, as amended (the "Merger Agreement"), by and among Trailblazer, Trailblazer Merger Sub, Ltd. ("Merger Sub"), Trailblazer Holdings, Inc. ("Holdings"), and Cyabra Strategy Ltd. ("Cyabra"), pursuant to which (a) Trailblazer merged with and into Holdings, with Holdings as the surviving entity of the merger (the "Parent Merger"), and (b) Merger Sub merged with and into Cyabra, with Cyabra as the surviving entity of the merger (together with the Parent Merger and all other transactions contemplated by the Merger Agreement, the "Business Combination"), following which Merger Sub ceased to exist and Cyabra became a wholly owned subsidiary of Holdings. After giving effect to the Business Combination, Holdings changed its name to the Issuer.

F2 · shares: Pursuant to the Merger Agreement, 160,000 ordinary shares of Cyabra held by the Reporting Person that were outstanding immediately prior to the effective time of the Business Combination (the "Effective Time") were, as of the Effective Time, converted into 577,549 shares of the Issuer.

F1 · price: Received in connection with the Issuer's business combination with Trailblazer Merger Corporation I ("Trailblazer"), in accordance with the terms of the Merger Agreement, dated July 22, 2024, as amended (the "Merger Agreement"), by and among Trailblazer, Trailblazer Merger Sub, Ltd. ("Merger Sub"), Trailblazer Holdings, Inc. ("Holdings"), and Cyabra Strategy Ltd. ("Cyabra"), pursuant to which (a) Trailblazer merged with and into Holdings, with Holdings as the surviving entity of the merger (the "Parent Merger"), and (b) Merger Sub merged with and into Cyabra, with Cyabra as the surviving entity of the merger (together with the Parent Merger and all other transactions contemplated by the Merger Agreement, the "Business Combination"), following which Merger Sub ceased to exist and Cyabra became a wholly owned subsidiary of Holdings. After giving effect to the Business Combination, Holdings changed its name to the Issuer.

F2 · price: Pursuant to the Merger Agreement, 160,000 ordinary shares of Cyabra held by the Reporting Person that were outstanding immediately prior to the effective time of the Business Combination (the "Effective Time") were, as of the Effective Time, converted into 577,549 shares of the Issuer.

F1 · balance_after: Received in connection with the Issuer's business combination with Trailblazer Merger Corporation I ("Trailblazer"), in accordance with the terms of the Merger Agreement, dated July 22, 2024, as amended (the "Merger Agreement"), by and among Trailblazer, Trailblazer Merger Sub, Ltd. ("Merger Sub"), Trailblazer Holdings, Inc. ("Holdings"), and Cyabra Strategy Ltd. ("Cyabra"), pursuant to which (a) Trailblazer merged with and into Holdings, with Holdings as the surviving entity of the merger (the "Parent Merger"), and (b) Merger Sub merged with and into Cyabra, with Cyabra as the surviving entity of the merger (together with the Parent Merger and all other transactions contemplated by the Merger Agreement, the "Business Combination"), following which Merger Sub ceased to exist and Cyabra became a wholly owned subsidiary of Holdings. After giving effect to the Business Combination, Holdings changed its name to the Issuer.

F2 · balance_after: Pursuant to the Merger Agreement, 160,000 ordinary shares of Cyabra held by the Reporting Person that were outstanding immediately prior to the effective time of the Business Combination (the "Effective Time") were, as of the Effective Time, converted into 577,549 shares of the Issuer.

F3 · ownership.nature: Held by IBI Trust Management in trust for the Reporting Person.

Read SEC document
March 27, 2026 Filed Apr 1, 2026 01:09 UTC
Vu SonnyDirector
GrantStock Option (Right to Buy) · Derivative 12,013 Not disclosed Strike: $1.00 Not disclosed
Disclosure

SEC source: 0001213900-26-037856 · ownership.xml · derivative · entry 4

Vu Sonny · CIK 0002045863 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 12,013

Underlying: Common Stock · 12,013 shares

Expires 2032-07-17

F7 · price: Pursuant to the Merger Agreement, each option to purchase ordinary shares of Cyabra held by FF Alabaster, LLC that was outstanding immediately prior to the Effective Time for an aggregate of 3,328 ordinary shares was, as of the Effective Time, cancelled in consideration for the issuance of an option to purchase shares of the Issuer, subject to the same terms and conditions as were applicable to the corresponding Cyabra option immediately prior to the Effective Time, pursuant to the 2026 Plan.

F5 · derivative.exercise_date: The options were fully vested upon grant.

F4 · ownership.nature: The securities are held directly by FF Alabaster LLC.

Read SEC document
March 27, 2026 Filed Apr 1, 2026 01:09 UTC
Vu SonnyDirector
GrantStock Option (Right to Buy) · Derivative 18,048 Not disclosed Strike: $1.00 Not disclosed
Disclosure

SEC source: 0001213900-26-037856 · ownership.xml · derivative · entry 3

Vu Sonny · CIK 0002045863 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,048

Underlying: Common Stock · 18,048 shares

Expires 2032-07-17

F6 · price: Pursuant to the Merger Agreement, each option to purchase ordinary shares of Cyabra held by the Reporting Person that was outstanding immediately prior to the Effective Time for an aggregate of 5,000 ordinary shares was, as of the Effective Time, cancelled in consideration for the issuance of an option to purchase shares of the Issuer, subject to the same terms and conditions as were applicable to the corresponding Cyabra option immediately prior to the Effective Time, pursuant to the Cyabra, Inc. 2026 Omnibus Equity Incentive Plan (the "2026 Plan.").

F5 · derivative.exercise_date: The options were fully vested upon grant.

Read SEC document
March 27, 2026 Filed Apr 1, 2026 01:09 UTC
Vu SonnyDirector
GrantCommon Stock 273,278 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-26-037856 · ownership.xml · nonDerivative · entry 2

Vu Sonny · CIK 0002045863 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 273,278

F1 · price: Received in connection with the Issuer's business combination with Trailblazer Merger Corporation I ("Trailblazer"), in accordance with the terms of the Merger Agreement, dated July 22, 2024, as amended (the "Merger Agreement"), by and among Trailblazer, Trailblazer Merger Sub, Ltd. ("Merger Sub"), Trailblazer Holdings, Inc. ("Holdings"), and Cyabra Strategy Ltd. ("Cyabra"), pursuant to which (a) Trailblazer merged with and into Holdings, with Holdings as the surviving entity of the merger (the "Parent Merger"), and (b) Merger Sub merged with and into Cyabra, with Cyabra as the surviving entity of the merger (together with the Parent Merger and all other transactions contemplated by the Merger Agreement, the "Business Combination"), following which Merger Sub ceased to exist and Cyabra became a wholly owned subsidiary of Holdings. After giving effect to the Business Combination, Holdings changed its name to the Issuer.

F3 · price: Pursuant to the Merger Agreement, 75,707 ordinary shares of Cyabra held by FF Alabaster LLC that was outstanding immediately prior to the Effective Time were, as of the Effective Time, converted into 273,278 shares of the Issuer.

F4 · ownership.nature: The securities are held directly by FF Alabaster LLC.

Read SEC document
March 27, 2026 Filed Apr 1, 2026 01:09 UTC
Vu SonnyDirector
GrantCommon Stock 27,329 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-26-037856 · ownership.xml · nonDerivative · entry 1

Vu Sonny · CIK 0002045863 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,329

F1 · price: Received in connection with the Issuer's business combination with Trailblazer Merger Corporation I ("Trailblazer"), in accordance with the terms of the Merger Agreement, dated July 22, 2024, as amended (the "Merger Agreement"), by and among Trailblazer, Trailblazer Merger Sub, Ltd. ("Merger Sub"), Trailblazer Holdings, Inc. ("Holdings"), and Cyabra Strategy Ltd. ("Cyabra"), pursuant to which (a) Trailblazer merged with and into Holdings, with Holdings as the surviving entity of the merger (the "Parent Merger"), and (b) Merger Sub merged with and into Cyabra, with Cyabra as the surviving entity of the merger (together with the Parent Merger and all other transactions contemplated by the Merger Agreement, the "Business Combination"), following which Merger Sub ceased to exist and Cyabra became a wholly owned subsidiary of Holdings. After giving effect to the Business Combination, Holdings changed its name to the Issuer.

F2 · price: Pursuant to the Merger Agreement, 7,571 ordinary shares of Cyabra held by the Reporting Person that were outstanding immediately prior to the effective time of the Business Combination (the "Effective Time") were, as of the Effective Time, converted into 27,329 shares of the Issuer.

Read SEC document
March 27, 2026 Filed Apr 1, 2026 01:08 UTC
Heymann EmmanuelChief Revenue Officer
GrantStock Option(Right to Buy) · Derivative 28,883 Not disclosed Strike: $7.53 Not disclosed
Disclosure

SEC source: 0001213900-26-037850 · ownership.xml · derivative · entry 2

Heymann Emmanuel · CIK 0002045608 · Chief Revenue Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,883

Underlying: Common Stock · 28,883 shares

Expires 2033-02-19

F2 · price: Received in connection with the Issuer's business combination with Trailblazer Merger Corporation I ("Trailblazer"), in accordance with the terms of the Merger Agreement, dated July 22, 2024, as amended (the "Merger Agreement"), by and among Trailblazer, Trailblazer Merger Sub, Ltd. ("Merger Sub"), Trailblazer Holdings, Inc. ("Holdings"), and Cyabra Strategy Ltd. ("Cyabra"), pursuant to which (a) Trailblazer merged with and into Holdings, with Holdings as the surviving entity of the merger (the "Parent Merger"), and (b) Merger Sub merged with and into Cyabra, with Cyabra as the surviving entity of the merger (together with the Parent Merger and all other transactions contemplated by the Merger Agreement, the "Business Combination"), following which Merger Sub ceased to exist and Cyabra became a wholly owned subsidiary of Holdings. After giving effect to the Business Combination, Holdings changed its name to the Issuer.

F5 · price: Pursuant to the Merger Agreement, options to purchase an aggregate of 8,000 ordinary shares of Cyabra held by the Reporting Person that was outstanding immediately prior to the Effective Time were, as of the Effective Time, cancelled in consideration for the issuance of an option to purchase shares of the Issuer reported herein under the 2026 Plan, subject to the same terms and conditions as were applicable to the corresponding Cyabra option immediately prior to the Effective Time (the "January 2025 Replacement Option").

F4 · derivative.exercise_date: Pursuant to the terms of the January 2025 Replacement Option (as defined below), the January 2025 Replacement Option has vested in part and shall vest over a period of three (3) years and ten (10) months as follows: The January 2025 Replacement Option shall vest over a period of three (3) years and ten (10) months as follows: Twenty-five percent (25%) vested upon the lapse of 10 months from January 1, 2025 (the "2025 Vesting Commencement Date") and the remaining 75% of the shares subject to the January 2025 Replacement Option have vested and shall vest on equal portions upon the lapse of the last day of each subsequent month thereafter, so that the January 2025 Replacement Option shall be fully vested by the thirty-sixth (36) month from the 2025 Vesting Commencement Date, pursuant to the 2026 Plan.

Read SEC document
March 27, 2026 Filed Apr 1, 2026 01:08 UTC
Heymann EmmanuelChief Revenue Officer
GrantStock Option(Right to Buy) · Derivative 25,264 Not disclosed Strike: $1.00 Not disclosed
Disclosure

SEC source: 0001213900-26-037850 · ownership.xml · derivative · entry 1

Heymann Emmanuel · CIK 0002045608 · Chief Revenue Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,264

Underlying: Common Stock · 25,264 shares

Expires 2033-02-19

F2 · price: Received in connection with the Issuer's business combination with Trailblazer Merger Corporation I ("Trailblazer"), in accordance with the terms of the Merger Agreement, dated July 22, 2024, as amended (the "Merger Agreement"), by and among Trailblazer, Trailblazer Merger Sub, Ltd. ("Merger Sub"), Trailblazer Holdings, Inc. ("Holdings"), and Cyabra Strategy Ltd. ("Cyabra"), pursuant to which (a) Trailblazer merged with and into Holdings, with Holdings as the surviving entity of the merger (the "Parent Merger"), and (b) Merger Sub merged with and into Cyabra, with Cyabra as the surviving entity of the merger (together with the Parent Merger and all other transactions contemplated by the Merger Agreement, the "Business Combination"), following which Merger Sub ceased to exist and Cyabra became a wholly owned subsidiary of Holdings. After giving effect to the Business Combination, Holdings changed its name to the Issuer.

F3 · price: Pursuant to the Merger Agreement, options to purchase an aggregate of 7,000 ordinary shares of Cyabra held by the Reporting Person that was outstanding immediately prior to the effective time of the Business Combination (the "Effective Time") were, as of the Effective Time, cancelled in consideration for the issuance of an option to purchase shares of the Issuer reported herein under the Cyabra, Inc. 2026 Omnibus Incentive Plan (the "2026 Plan"), subject to the same terms and conditions as were applicable to the corresponding Cyabra option immediately prior to the Effective Time (the "January 2023 Replacement Option").

F1 · derivative.exercise_date: Pursuant to the terms of the January 2023 Replacement Option (as defined below), the January 2023 Replacement Option has vested in part and shall vest over a period of three (3) years and ten (10) months as follows: The January 2023 Replacement Option vest over a period of three (3) years and ten (10) months as follows: Twenty-five percent (25%) vested upon the lapse of 10 months from January 1, 2023 (the "2023 Vesting Commencement Date") and the remaining 75% of the shares subject to the January 2023 Replacement Option has vested and shall vest on equal portions upon the lapse of the last day of each subsequent month thereafter, so that the January 2023 Replacement Option shall be fully vested by the thirty-sixth (36) month from the 2023 Vesting Commencement Date.

Read SEC document
March 27, 2026 Filed Apr 1, 2026 00:47 UTC GrantStock Option (Right to Buy) · Derivative 144,387 Not disclosed Strike: $7.53 Not disclosed
Disclosure

SEC source: 0001213900-26-037828 · ownership.xml · derivative · entry 1

Sheeran Josette · CIK 0001835674 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 144,387

Underlying: Common Stock · 144,387 shares

Expires 2035-01-08

F2 · price: Received in connection with the Issuer's business combination with Trailblazer Merger Corporation I ("Trailblazer"), in accordance with the terms of the Merger Agreement, dated July 22, 2024, as amended (the "Merger Agreement"), by and among Trailblazer, Trailblazer Merger Sub, Ltd. ("Merger Sub"), Trailblazer Holdings, Inc. ("Holdings"), and Cyabra Strategy Ltd. ("Cyabra"), pursuant to which (a) Trailblazer merged with and into Holdings, with Holdings as the surviving entity of the merger (the "Parent Merger"), and (b) Merger Sub merged with and into Cyabra, with Cyabra as the surviving entity of the merger (together with the Parent Merger and all other transactions contemplated by the Merger Agreement, the "Business Combination"), following which Merger Sub ceased to exist and Cyabra became a wholly owned subsidiary of Holdings. After giving effect to the Business Combination, Holdings changed its name to the Issuer.

F3 · price: Pursuant to the Merger Agreement, each option to purchase ordinary shares of Cyabra held by the Reporting Person that was outstanding immediately prior to the effective time of the Business Combination (the "Effective Time") for an aggregate of 40,000 ordinary shares was, as of the Effective Time, cancelled in consideration for the issuance of an option to purchase shares of the Issuer reported herein (the "Replacement Options"), subject to the same terms and conditions as were applicable to the corresponding Cyabra option immediately prior to the Effective Time.

F1 · derivative.exercise_date: Pursuant to the terms of the Replacement Options (as defined below), the options have vested in part and shall vest over a period of three (3) years starting on December 14, 2024 (the Vesting Commencement Date) as follows: (i) 16.7% vested upon the lapse of 6 months from the Vesting Commencement Date; and (ii) 1/12 of the options have vested and shall vest on equal portions upon the lapse of each subsequent quarter thereafter, so that all options shall be fully vested by the third anniversary of the Vesting Commencement Date, pursuant to the Cyabra, Inc. 2026 Omnibus Equity Incentive Plan.

Read SEC document
March 27, 2026 Filed Apr 1, 2026 00:48 UTC
Sandler YaelChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 101,071 Not disclosed Strike: $0.16 Not disclosed
Disclosure

SEC source: 0001213900-26-037829 · ownership.xml · derivative · entry 1

Sandler Yael · CIK 0001717067 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 101,071

Underlying: Common Stock · 101,071 shares

Expires 2035-01-08

F2 · price: Received in connection with the Issuer's business combination with Trailblazer Merger Corporation I ("Trailblazer"), in accordance with the terms of the Merger Agreement, dated July 22, 2024, as amended (the "Merger Agreement"), by and among Trailblazer, Trailblazer Merger Sub, Ltd. ("Merger Sub"), Trailblazer Holdings, Inc. ("Holdings"), and Cyabra Strategy Ltd. ("Cyabra"), pursuant to which (a) Trailblazer merged with and into Holdings, with Holdings as the surviving entity of the merger (the "Parent Merger"), and (b) Merger Sub merged with and into Cyabra, with Cyabra as the surviving entity of the merger (together with the Parent Merger and all other transactions contemplated by the Merger Agreement, the "Business Combination"), following which Merger Sub ceased to exist and Cyabra became a wholly owned subsidiary of Holdings. After giving effect to the Business Combination, Holdings changed its name to the Issuer.

F3 · price: Pursuant to the Merger Agreement, each option to purchase ordinary shares of Cyabra held by the Reporting Person that was outstanding immediately prior to the effective time of the Business Combination (the "Effective Time") for an aggregate of 28,000 ordinary shares was, as of the Effective Time, cancelled in consideration for the issuance of an option to purchase shares of the Issuer reported herein (the "Replacement Options"), subject to the same terms and conditions as were applicable to the corresponding Cyabra option immediately prior to the Effective Time.

F1 · derivative.exercise_date: Pursuant to the terms of the Replacement Options (as defined below), the options have vested in part and shall vest over a period of four (4) years starting on July 2, 2024 (the "Vesting Commencement Date") as follows: (i) 25% vested upon the lapse of 12 months from the Vesting Commencement Date; and (ii) 1/12 of the remaining unvested options shall vest on equal portions upon the lapse of each subsequent quarter thereafter, so that all options shall be fully vested by the third anniversary of the Vesting Commencement Date, pursuant to the Cyabra Inc. 2026 Omnibus Equity Incentive Plan.

Read SEC document
March 27, 2026 Filed Apr 1, 2026 00:45 UTC GrantStock Option(Right to Buy) · Derivative 101,072 Not disclosed Strike: $2.94 Not disclosed
Disclosure

SEC source: 0001213900-26-037826 · ownership.xml · derivative · entry 1

Pompeo Michael · CIK 0002045605 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 101,072

Underlying: Common Stock · 101,072 shares

Expires 2034-04-15

F2 · price: Received in connection with the Issuer's business combination with Trailblazer Merger Corporation I ("Trailblazer"), in accordance with the terms of the Merger Agreement, dated July 22, 2024, as amended (the "Merger Agreement"), by and among Trailblazer, Trailblazer Merger Sub, Ltd., ("Merger Sub"), Trailblazer Holdings, Inc. ("Holdings"), and Cyabra Strategy Ltd. ("Cyabra"), pursuant to which (a) Trailblazer merged with and into Holdings, with Holdings as the surviving entity of the merger (the "Parent Merger"), and (b) Merger Sub merged with and into Cyabra, with Cyabra as the surviving entity of the merger (together with the Parent Merger and all other transactions contemplated by the Merger Agreement, the "Business Combination"), following which Merger Sub ceased to exist and Cyabra became a wholly owned subsidiary of Holdings. After giving effect to the Business Combination, Holdings changed its name to the Issuer.

F3 · price: Pursuant to the Merger Agreement, each option to purchase ordinary shares of Cyabra held by the Reporting Person that was outstanding immediately prior to the effective time of the Business Combination (the "Effective Time") for an aggregate of 28,000 ordinary shares was, as of the Effective Time, cancelled in consideration for the issuance of an option to purchase shares of the Issuer reported herein, subject to the same terms and conditions as were applicable to the corresponding Cyabra option immediately prior to the Effective Time, pursuant to the Cyabra, Inc. 2026 Equity Incentive Plan.

F1 · derivative.exercise_date: The options were fully vested upon grant.

Read SEC document
March 27, 2026 Filed Apr 1, 2026 00:46 UTC GrantStock Option(Right to Buy) · Derivative 14,436 Not disclosed Strike: $1.00 Not disclosed
Disclosure

SEC source: 0001213900-26-037827 · ownership.xml · derivative · entry 1

Madon Michael P · CIK 0001636174 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,436

Underlying: Common Stock · 14,436 shares

Expires 2035-01-08

F2 · price: Received in connection with the Issuer's business combination with Trailblazer Merger Corporation I ("Trailblazer"), in accordance with the terms of the Merger Agreement, dated July 22, 2024, as amended (the "Merger Agreement"), by and among Trailblazer, Trailblazer Merger Sub, Ltd. ("Merger Sub"), Trailblazer Holdings, Inc. ("Holdings"), and Cyabra Strategy Ltd. ("Cyabra"), pursuant to which (a) Trailblazer merged with and into Holdings, with Holdings as the surviving entity of the merger (the "Parent Merger"), and (b) Merger Sub merged with and into Cyabra, with Cyabra as the surviving entity of the merger (together with the Parent Merger and all other transactions contemplated by the Merger Agreement, the "Business Combination"), following which Merger Sub ceased to exist and Cyabra became a wholly owned subsidiary of Holdings. After giving effect to the Business Combination, Holdings changed its name to the Issuer.

F3 · price: Pursuant to the Merger Agreement, each option to purchase ordinary shares of Cyabra held by the Reporting Person that was outstanding immediately prior to the effective time of the Business Combination (the "Effective Time") for an aggregate of 4,000 ordinary shares was, as of the Effective Time, cancelled in consideration for the issuance of an option to purchase shares of the Issuer reported herein, subject to the same terms and conditions as were applicable to the corresponding Cyabra option immediately prior to the Effective Time, pursuant to the Cyabra, Inc. 2026 Omnibus Equity Incentive Plan.

F1 · derivative.exercise_date: The options were fully vested upon grant.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.